J 2024

Generation of human induced pluripotent stem cell lines from patients with a RYR2 gene variant c.14201A>G (p.Y4734C): Implications for idiopathic ventricular fibrillation and catecholaminergic polymorphic ventricular tachycardia

ÇELIKER, Canan, Štefan ZELENÁK, Samuel LIETAVA, Jiří PACHERNÍK, Markéta BÉBAROVÁ et. al.

Basic information

Original name

Generation of human induced pluripotent stem cell lines from patients with a RYR2 gene variant c.14201A>G (p.Y4734C): Implications for idiopathic ventricular fibrillation and catecholaminergic polymorphic ventricular tachycardia

Authors

ÇELIKER, Canan (792 Turkey, belonging to the institution), Štefan ZELENÁK (703 Slovakia, belonging to the institution), Samuel LIETAVA (703 Slovakia, belonging to the institution), Jiří PACHERNÍK (203 Czech Republic, belonging to the institution), Markéta BÉBAROVÁ (203 Czech Republic, belonging to the institution), Jana ZÍDKOVÁ (203 Czech Republic, belonging to the institution), Tomáš NOVOTNÝ (203 Czech Republic, belonging to the institution) and Tomáš BÁRTA (203 Czech Republic, belonging to the institution)

Edition

Stem cell research, Amsterdam, Elsevier, 2024, 1873-5061

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

10601 Cell biology

Country of publisher

Netherlands

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 1.200 in 2022

Organization unit

Faculty of Medicine

UT WoS

001302477700001

Keywords in English

human induced pluripotent stem cell lines; RYR2

Tags

International impact, Reviewed
Změněno: 23/9/2024 14:20, Mgr. Tereza Miškechová

Abstract

V originále

Human induced pluripotent stem cell (iPSC) lines were generated from peripheral blood mononuclear cells (PBMCs) isolated from two related patients diagnosed with either idiopathic ventricular fibrillation or catecholaminergic polymorphic ventricular tachycardia, carrying an unknown variant in the RYR2 gene, c.14201A>G (p.Y4734C) and one healthy related individual. Reprogramming was done using a commercially available Epi5 Reprogramming Kit. The pluripotency of the iPSC lines was verified by the expression of pluripotency markers and by their capacity to differentiate into all three embryonic germ layers in vitro. These iPSC lines are available for functional analysis and in vitro studies of RYR2 channelopathy.

Links

MUNI/A/1598/2023, interní kód MU
Name: Zdroje pro tkáňové inženýrství 14
Investor: Masaryk University, Resources pro tissue engineering 14
NU22-02-00348, research and development project
Name: Funkční hodnocení genetických variant u případů klinicky „skutečné“ idiopatické fibrilace komor: in vitro a in silico modelování s cílem odhalit arytmogenní mechanismus
Investor: Ministry of Health of the CR, Subprogram 1 - standard